Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Open in API
Filings indexed 1,123 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Intimation of Transfer of Equity Shares to IEPF Authority in respect of unclaimed dividend for the financial year 2018-19.
Regulatory Filings Classification · 89% confidence The document is a formal intimation to stock exchanges and shareholders that equity shares with unclaimed dividends are being transferred to the Investor Education and Protection Fund (IEPF) under Section 124 of the Companies Act. It is a compliance/ regulatory announcement rather than a financial report, earnings release, management change, or dividend notice. It does not contain substantive financial statements or executive certifications of a particular report; it simply notifies a corporate action and legal compliance. Thus it falls under the general “Regulatory Filings” category (RNS).
2026-06-01 English
General Updates
Regulatory Filings Classification · 80% confidence The document is an intimation to stock exchanges regarding the transfer of unclaimed equity shares to the Investor Education and Protection Fund (IEPF) Authority under Company Law provisions. It is not a financial report, earnings release, M&A filing, dividend notice, or board/management change announcement. There is no substantive financial data or investor presentation content. It is a routine regulatory announcement and thus falls into the fallback category for miscellaneous regulatory filings (RNS).
2026-06-01 English
Copy of Newspaper Publication
Regulatory Filings Classification · 82% confidence The document is a letter to stock exchanges (BSE & NSE) submitting copies of newspaper advertisements regarding the transfer of unclaimed dividends and equity shares to the Investor Education and Protection Fund (IEPF). There is no substantive financial data or full report content. It is an announcement of a compliance action. Therefore, it fits the "Regulatory Filings" category (RNS).
2026-06-01 English
Submission of advertisement published in newspapers regarding notice for transfer of equity shares and unclaimed dividends to Investor Education and Protection Fund (IEPF) Account.
Regulatory Filings Classification · 85% confidence The document is a submission to stock exchanges enclosing newspaper advertisements regarding transfer of equity shares and unclaimed dividends to the Investor Education and Protection Fund (IEPF) in compliance with statutory rules. It is a routine regulatory/ compliance announcement, not an actual financial report, earnings release, meeting materials, or manager report. Therefore it falls under the general Regulatory Filings category.
2026-06-01 English
Annual Secretarial Compliance Report dated May 22, 2026 for the year ended March 31, 2026.
Regulatory Filings Classification · 83% confidence The document is a letter to stock exchanges submitting the Annual Secretarial Compliance Report under SEBI Listing Regulations, signed by the Company Secretary. It is a regulatory compliance filing (an officer attestation/compliance certificate) rather than a full annual or interim financial report, earnings release, or other specific category. Under our taxonomy, this falls into “Regulatory Filings (RNS)” as a general compliance submission.
2026-05-27 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 85% confidence The document is a letter from Unichem Laboratories Ltd. to the BSE and NSE dated May 23, 2026, stating that the unaudited quarterly and audited full‐year financial results for the period ended March 31, 2026 have been published in newspapers and attaching newspaper cuttings. It does not present the financial statements themselves but rather notifies the exchanges that the results have been published. Therefore, it is an announcement of report publication (RPA), not the report itself.
2026-05-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.